In the video, Dr. David Martin, creator of the public equity index – the CNBC IQ100 powered by M·CAM® which now is reported as a leading economic indicator for the U.S. and Global Innovation Economy, tells how neither the Corona virus nor the spike protein are novel developments at all.
US Patent #6372224 was the spike protein virus vaccine for the canine Corona virus, in 1999.
The U.S. made SARS and patented it in April 2002, before any outbreaks in Asia, which followed several months later. It was not only engineering, but was modified by gene sequencing technology taking computer code and turning it into a pathogen. We harnessed Corona virus as a vector to transmit HIV-vaccines.
Dr. David Martin, on Corona Ausschuss, July 9, 2021
Before believing in the many “fact checkers” that seemingly debunk his claims, look up CIAs Operation Project Mockingbird.
Posted for educative purposes under THE FAIR USE NOTICE: These Videos may contain copyrighted (© ) material the use of which has not always been specifically authorized by the copyright owner. Such material is made available to advance understanding of ecological, political, human rights, economic, democracy, scientific, moral, ethical, and social justice issues, etc. It is believed that this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior general interest in receiving similar information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode “Copyright Disclaimer Under Section 107 of the Copyright Act 1976, allowance is made for “fair use” for purposes such as criticism, comment, news reporting, teaching, scholarship, and research. Fair use is a use permitted by copyright statute that might otherwise be infringing. Non-profit, educational or personal use tips the balance in favor of fair use.” Disclaimer: 17 Notwithstanding the Provisions of Sections 17 U.S.C. @ 106 and 17 U.S.C. @ 106A, the Fair Use of a Copyrighted work for Educational Purposes- Not For Profit- Non-Commercial.